[{"bbox": [88, 94, 372, 134], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [88, 167, 526, 205], "category": "Section-header", "text": "# India's In-Vitro Diagnostics Market"}, {"bbox": [90, 231, 248, 267], "category": "Section-header", "text": "## Introduction"}, {"bbox": [88, 296, 1564, 493], "category": "Text", "text": "The In-Vitro Diagnostics (IVD) market serves as a critical component of the healthcare infrastructure, facilitating early disease detection and accurate diagnosis. With the increasing demand for timely and precise medical testing, IVD has become crucial in clinical decision-making, directly influencing treatment outcomes. The market segments are based on usability and application, offering a comprehensive range of diagnostic solutions tailored to varying medical requirements. While the sector has been expanding at a steady pace, segments such as immunochemistry, clinical chemistry, hematology, and molecular diagnostics continue to gain traction, driven by technological advancements and a gradual transition toward automation and point-of-care testing."}, {"bbox": [88, 518, 1564, 652], "category": "Text", "text": "The growing burden of chronic conditions, including diabetes, cardiovascular diseases, and cancer, alongside the ongoing prevalence of infectious diseases such as tuberculosis, dengue, and COVID-19, has been a key demand drivers for IVD solutions. Additionally, the expansion of diagnostic laboratories, improved accessibility to healthcare services, and rising awareness of preventive diagnostics are shaping the market's growth trajectory."}, {"bbox": [88, 679, 1564, 779], "category": "Text", "text": "As India's healthcare sector, the IVD industry is poised for steady growth, fuelled by technological innovations, growing geriatric populations, cost-efficient solutions, and increased adoption. The industry is moving towards automation enhancing accuracy and efficiency in disease detection."}, {"bbox": [106, 779, 340, 815], "category": "Caption", "text": "## Market Landscape"}, {"bbox": [106, 838, 606, 878], "category": "Caption", "text": "Chart 8: India's In-Vitro Diagnostics Market"}, {"bbox": [106, 873, 1355, 1612], "category": "Picture"}, {"bbox": [88, 1645, 1564, 1905], "category": "Text", "text": "The India In-Vitro Diagnostics (IVD) market has experienced dynamic shifts, primarily driven by the COVID-19 pandemic. The market surged from 1,237 million USD in CY19 to 2,142 million USD in CY21 due to increased testing demand, followed by a sharp decline in CY22 and CY23 due to a high base from COVID-19 testing, which was not sustainable for continued growth, along with reduced pandemic-related testing. However, with growing healthcare awareness, and rising prevalence of chronic diseases, the market began recovering in CY24 and is projected to grow at a CAGR of up to 12.0%, reaching 2,978 million USD by CY30. This growth is likely to be driven by development of testing facilities and the rising burden of lifestyle diseases. With a steady demand for preventive healthcare, the market is expected to continue growth momentum, solidifying its critical role in India's healthcare sector."}, {"bbox": [88, 1935, 518, 1973], "category": "Caption", "text": "## Market Segmentation by Test Type"}, {"bbox": [88, 1997, 882, 2034], "category": "Caption", "text": "Table 3: Description about the Tests Types in the In-Vitro Diagnostics"}, {"bbox": [88, 2029, 1564, 2097], "category": "Table", "text": "<table><thead><tr><td>Sr No.</td><td>Test Type</td><td>Description</td></tr></thead></table>"}]